Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pharmacyte Biotech, Inc. (PMCB) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pharmacyte Biotech, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1157075.
Total stock buying since 2026: $128,720.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 160,000 | $128,720 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-01 | 160,000 | $128,720 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-01-07 | Schechter Jonathan | Buy | 20,000 | .84 | 16,880 |
| 2026-01-07 | Silverman Joshua (CEO and President) | Buy | 40,000 | .83 | 33,320 |
| 2026-01-06 | Schechter Jonathan | Buy | 20,000 | .79 | 15,800 |
| 2026-01-06 | Silverman Joshua (CEO and President) | Buy | 30,000 | .79 | 23,670 |
| 2026-01-05 | Schechter Jonathan | Buy | 20,000 | .78 | 15,560 |
| 2026-01-05 | Silverman Joshua (CEO and President) | Buy | 30,000 | .78 | 23,490 |
Insider trading activities including stock purchases, stock sales, and option exercises of PMCB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pharmacyte Biotech, Inc. (symbol PMCB, CIK number 1157075) see the Securities and Exchange Commission (SEC) website.